Engineers Gate Manager LP Supernus Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 18,037 shares of SUPN stock, worth $743,665. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,037

Previous 13,293 35.69%

Holding current value

$743,665

Previous $480,000 22.92%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$31.17 - $40.0 $147,870 - $189,760	4,744 Added 35.69%	18,037 $590,000
Q4 2024 Feb 14, 2025	SELL	$31.89 - $37.83 $45,188 - $53,605	-1,417 Reduced 9.63%	13,293 $480,000
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $379,076 - $517,203	14,710 New	14,710 $458,000
Q1 2024 May 15, 2024	SELL	$27.11 - $35.17 $125,193 - $162,415	-4,618 Reduced 20.26%	18,174 $619,000
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $517,834 - $676,466	22,792 New	22,792 $659,000
Q4 2022 Feb 14, 2023	BUY	$31.09 - $37.88 $182,436 - $222,279	5,868 New	5,868 $209,000
Q1 2021 May 17, 2021	SELL	$24.15 - $31.45 $998,771 - $1.3 Million	-41,357 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $544,186 - $793,528	30,745 Added 289.72%	41,357 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $198,263 - $245,865	-9,815 Reduced 48.05%	10,612 $221,000
Q2 2020 Aug 17, 2020	BUY	$17.09 - $24.89 $349,097 - $508,428	20,427 New	20,427 $485,000
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $2.34 Million - $4 Million	-162,156 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $3.23 Million - $4.72 Million	162,156 New	162,156 $3.85 Million
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $1.19 Million - $1.54 Million	-39,731 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $179,120 - $229,517	-5,466 Reduced 12.09%	39,731 $1.39 Million
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $1.39 Million - $2.24 Million	45,197 New	45,197 $1.5 Million
Q3 2018 Nov 01, 2018	SELL	$42.7 - $56.55 $2.34 Million - $3.1 Million	-54,903 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$44.1 - $59.85 $574,137 - $779,187	-13,019 Reduced 19.17%	54,903 $3.29 Million
Q1 2018 May 07, 2018	BUY	$37.15 - $46.9 $897,358 - $1.13 Million	24,155 Added 55.19%	67,922 $3.11 Million
Q4 2017 Feb 01, 2018	SELL	$36.4 - $42.6 $215,597 - $252,319	-5,923 Reduced 11.92%	43,767 $1.74 Million
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $1.83 Million - $2.47 Million	49,690	49,690 $1.99 Million

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.4M

Call Options Held

8.8K

Put Options Held

6.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.21B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Supernus Pharmaceuticals, Inc. Transaction History